Lungpacer Medical, Inc.
Biotech · Series B · Regulation D 506(b) · PA · Filed July 2, 2026
- Offering amount
- $20.0M
- Exemption
- Reg D 506(b)
- Issuer state
- PA
- Filing date
- July 2, 2026
- Signature date
- June 30, 2026
- CIK
- 0001708893
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Summary
Auto-generatedLungpacer Medical, Inc. is a medical device/biotech company based on the 'Lungpacer' name. $20M offering anchors series-b stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.